Sundrug Co.,Ltd. (TYO: 9989)

Sundrug Co.,Ltd. Statistics

Total Valuation

Sundrug Co.,Ltd. has a market cap or net worth of JPY 458.63 billion. The enterprise value is 429.65 billion.

Market Cap	458.63B
Enterprise Value	429.65B

Important Dates

The next estimated earnings date is Friday, February 14, 2025.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Sundrug Co.,Ltd. has 116.97 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	n/a
Shares Outstanding	116.97M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	4.59%
Owned by Institutions (%)	27.46%
Float	67.02M

Valuation Ratios

The trailing PE ratio is 15.63 and the forward PE ratio is 14.60. Sundrug Co.,Ltd.'s PEG ratio is 3.51.

PE Ratio	15.63
Forward PE	14.60
PS Ratio	0.59
PB Ratio	1.76
P/TBV Ratio	1.82
P/FCF Ratio	153.18
P/OCF Ratio	n/a
PEG Ratio	3.51

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.53, with an EV/FCF ratio of 143.50.

EV / Earnings	14.64
EV / Sales	0.55
EV / EBITDA	7.53
EV / EBIT	10.55
EV / FCF	143.50

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.13.

Current Ratio	1.74
Quick Ratio	0.76
Debt / Equity	0.13
Debt / EBITDA	0.59
Debt / FCF	11.49
Interest Coverage	577.76

Financial Efficiency

Return on equity (ROE) is 11.61% and return on invested capital (ROIC) is 9.63%.

Return on Equity (ROE)	11.61%
Return on Assets (ROA)	6.58%
Return on Capital (ROIC)	9.63%
Revenue Per Employee	116.43M
Profits Per Employee	4.40M
Employee Count	6,662
Asset Turnover	1.96
Inventory Turnover	6.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-9.70%
50-Day Moving Average	3,794.36
200-Day Moving Average	4,118.22
Relative Strength Index (RSI)	58.53
Average Volume (20 Days)	473,255

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sundrug Co.,Ltd. had revenue of JPY 775.66 billion and earned 29.34 billion in profits. Earnings per share was 250.88.

Revenue	775.66B
Gross Profit	196.04B
Operating Income	41.60B
Pretax Income	41.14B
Net Income	29.34B
EBITDA	57.92B
EBIT	41.60B
Earnings Per Share (EPS)	250.88

Balance Sheet

The company has 63.39 billion in cash and 34.42 billion in debt, giving a net cash position of 28.98 billion or 247.74 per share.

Cash & Cash Equivalents	63.39B
Total Debt	34.42B
Net Cash	28.98B
Net Cash Per Share	247.74
Equity (Book Value)	260.76B
Book Value Per Share	2,229.34
Working Capital	86.10B

Cash Flow

In the last 12 months, operating cash flow was 36.96 billion and capital expenditures -33.97 billion, giving a free cash flow of 2.99 billion.

Operating Cash Flow	36.96B
Capital Expenditures	-33.97B
Free Cash Flow	2.99B
FCF Per Share	25.60

Margins

Gross margin is 25.27%, with operating and profit margins of 5.36% and 3.78%.

Gross Margin	25.27%
Operating Margin	5.36%
Pretax Margin	5.30%
Profit Margin	3.78%
EBITDA Margin	7.47%
EBIT Margin	5.36%
FCF Margin	0.39%

Dividends & Yields

This stock pays an annual dividend of 130.00, which amounts to a dividend yield of 3.32%.

Dividend Per Share	130.00
Dividend Yield	3.32%
Dividend Growth (YoY)	14.02%
Years of Dividend Growth	5
Payout Ratio	45.43%
Buyback Yield	-0.02%
Shareholder Yield	3.30%
Earnings Yield	6.40%
FCF Yield	0.65%

Stock Splits

The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.

Last Split Date	Mar 29, 2017
Split Type	Forward
Split Ratio	2

Scores

Sundrug Co.,Ltd. has an Altman Z-Score of 5.16.

Altman Z-Score	5.16
Piotroski F-Score	n/a